Dexamethasone for Migraine - Dose Comparison Read more about Dexamethasone for Migraine - Dose Comparison
A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy Read more about A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma Read more about Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Sleep for Stroke Management and Recovery Trial Read more about Sleep for Stroke Management and Recovery Trial
5-Cog Battery for Detecting Cognitive Impairment and Dementia Read more about 5-Cog Battery for Detecting Cognitive Impairment and Dementia
CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS) Read more about CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)
Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy Read more about Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Read more about Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comp Read more about Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comp
A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib Read more about A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib